Olatec | NLRP3 | Small-molecule inhibitors | Phase II | olatec.com |
Inflazome/Roche | NLRP3 | Small-molecule inhibitors | Phase Ib | roche.com |
Novartis | NLRP3 | Small-molecule inhibitor acquired from IFM Tre | Phase I | novartis.com |
Genentech | NLRP3 | Small-molecule inhibitors acquired from Jecure therapeutics | Preclinical | gene.com |
NodThera | NLRP3 | Small-molecule inhibitors | Preclinical | www.nodthera.com |
Quench Bio | Gasdermin-D | Small-molecule inhibitors | Preclinical | quenchbio.com |
ZyVersa Therapeutics | ASC | Neutralizing antibody | Preclinical | www.zyversa.com |
Ardan ImmunoPharma | TMEM176B | Small-molecule inhibitors and activators | Preclinical | ardan-pharma.com |